ARTICLE | Company News
Medigene, 2A Pharma deal
January 6, 2017 8:35 PM UTC
Medigene granted 2A Pharma exclusive worldwide rights to develop and commercialize Medigene's preclinical adeno-associated virus-like particles (AAVLPs). Medigene is eligible to receive clinical, regu...